Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Analysts Suggest You Should Buy These Two Stocks but Hedge Funds Have Mixed Sentiments

Page 1 of 2

With the U.S. stock market rallying following news of increased consumer confidence, the two stocks have also been boosted by a positive reaction to a new wave of analyst ratings. Panera Bread Co (NASDAQ:PNRA) was awarded an ‘Outperform’ rating from analysts at Telsey Advisory Group, according to a new research report issued today. They also believe the stock could go as high as $225 per share. Sterne Agee CRT has also recently initiated coverage on Apple Inc. (NASDAQ:AAPL), with analysts believing the stock to be a ‘Buy’ and having set a price target of $150 per share. During the second quarter, hedge funds have become more attracted to Panera Bread, while Apple has lost some support, although it remained one of the most popular companies among the funds we track.

Apple, is AAPL a good stock to buy, NASDAQ:AAPL, Angelo Zino, S&P Capital IQ, music streaming, Spotify,

Panera Bread Co (NASDAQ:PNRA)‘s stock managed to stage a rally recently, following the August market sell-off, and is up 8.57% so far this month. Barclays analysts are also bullish on this stock, having reiterated their Overweight rating at the end of July and a price target of $215, while Maxim Group believes the stock is a ‘Hold’. During the second quarter, the number of hedge funds holding a stake in Panera increased to 27, from 25 at the end of March, while the value of their aggregate positions surged by 52% to $562 million. Their investment also accounts for 12% of the company’s total outstanding stock.

Follow Panera Bread Co (NASDAQ:PNRA)
Trade (NASDAQ:PNRA) Now!

An everyday investor does not have the time or the required skill-set to carry out an in-depth analysis of equities and identify companies with the best future prospects. However, it is also not a good idea to pay the egregiously high fees that investment firms charge for their stock-picking expertise. Thus a retail investor is better off to monkey the most popular stock picks among hedge funds by him or herself. But not just any picks. Our research has shown that a portfolio based on hedge funds’ top stock picks (which are invariably comprised of large- and mega-cap companies) falls considerably short of a portfolio based on their best small-cap stock picks. The most popular large-cap stocks among hedge funds lagged the market by an average of 7.0 basis points per month in our backtests, whereas the 15 most popular small-cap ideas among hedge funds outperformed the market by nearly a percentage point per month over the same period between 1999 and 2012. Since officially launching our small-cap strategy in August 2012 it has performed just as predicted, beating the market by over 60 percentage points and returning over 118%, while hedge funds have collectively underperformed the market (read more details here).

Luxor Capital Group holds the largest stake on Panera Bread Co (NASDAQ:PNRA) among the hedge funds that we follow. Christian Leone, the fund’s manager, increased his stake in the company by 184% to 997,838 shares during the second quarter, while Israel Englander boosted his stake by 260% to amass 322,824 shares according to Millennium Management’s latest 13F filing. James Crichton, the manager of Hitchwood Capital Management, has decided to join the party as well and has initiated a stake in Panera Bread, stockpiling 350,000 shares by the end of the quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!